Catalyst Pharma gains after report Italy's Angelini exploring acquisition

Catalyst Pharmaceuticals

27/04/2026 18:27

** Catalyst Pharmaceuticals CPRX.O shares rise 7.4% to $29.40

** Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst as it looks at deals to expand its footprint globally, Bloomberg News reports, citing people familiar with the matter

** Discussions are at a preliminary stage, the report said, adding Angelini is working with advisers as it studies a possible purchase of CPRX

** Reuters has not independently verified the report

** Stock up 27.6% YTD

 (Reporting by Sriparna Roy in Bengaluru)

 ((Sriparna.Roy@thomsonreuters.com;))